Survivorship beyond convalescence: 48-month quality-of-life outcomes after treatment for localized prostate cancer

122Citations
Citations of this article
77Readers
Mendeley users who have this article in their library.

Abstract

Decision making for treatment of localized prostate cancer is often guided by therapeutic side-effect profiles. We sought to assess health-related quality-of-life outcomes for patients 48 months after treatment for localized prostate cancer. Men treated for localized prostate cancer (N = 475) were evaluated before treatment and at 11 intervals during the 48 months after intervention. Changes in mean health-related quality-of-life scores and the probability of regaining baseline levels of health-related quality of life were compared between treatment groups. All statistical tests were two-sided. Urinary incontinence was more common after prostatectomy (n = 307) than after brachytherapy (n = 90) or external beam radiation therapy (n = 78) (both P

Cite

CITATION STYLE

APA

Gore, J. L., Kwan, L., Lee, S. P., Reiter, R. E., & Litwin, M. S. (2009). Survivorship beyond convalescence: 48-month quality-of-life outcomes after treatment for localized prostate cancer. Journal of the National Cancer Institute, 101(12), 888–892. https://doi.org/10.1093/jnci/djp114

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free